Sotera Health (Broadview Heights, Ohio) has acquired New Jersey-based Gibraltar Laboratories to expand the analytical testing capabilities of the company’s Nelson Labs business. The financial details of the deal were not disclosed.
Gibraltar Laboratories (Fairfield, N.J.) has been owned and operated by the Prince family since 1970 and has two laboratories in the New Jersey tri-state area. It is an outsourced providers of microbiology and analytical chemistry testing for pharmaceutical and medical device manufacturers.
“Gibraltar Laboratories is a well-respected laboratory known for its strong customer relationships with U.S.-based pharmaceutical manufacturers,” Michael B. Petras, Jr., CEO of Sotera Health, said. “In addition to its testing expertise, Gibraltar’s facilities are located in the Northeast pharmaceutical corridor, home to many of the top pharmaceutical manufacturers in the United States. This acquisition will expand our presence in this important region and further strengthen our testing capabilities for the pharmaceutical industry. We welcome Gibraltar’s strong management and expert staff as they join our mission of Safeguarding Global Health.”
The acquisition of Gibraltar will complement the Nelson Labs business. Gibraltar’s experience in pharmaceutical products and analytical testing capabilities will strengthen Nelson Labs’s expertise in medical device microbiology and expert advisory services.
“Gibraltar’s offerings and the strategic location of its facilities will be a great benefit to our mutual customers, who value working with a trusted partner that can consistently deliver quality, service and expertise,” Jeff Nelson, president of Nelson Labs, said. “The Gibraltar team is known for these values and also has an excellent reputation for designing specialized studies that help manufacturers prove the safety, efficacy and regulatory compliance of their products. I am also personally excited to be working directly with Dr. Daniel Prince, who I consider a leading thinker in our field.”
Gibraltar’s facilities are also FDA registered and ISO 17025 accredited and have the distinction of being accredited for both the microbiological and chemical fields.
“Through the commitment of three generation of the Prince family, as well as our experienced staff of microbiology and chemistry professionals, we have earned a reputation as a reliable, responsive and highly professional partner for our customers, and we know we have found the same in Sotera Health,” Daniel Prince, president of Gibraltar Laboratories, said. “My goal is for Gibraltar to continue to build on its long-standing reputation of excellence and continue to expand its offerings. We accomplish this by becoming part of Sotera Health, a global company whose breadth of services and expansive reach provide extraordinary value to the industries we are proud to serve.”
The acquisition does not include Gibraltar Labs’s Prince Sterilization Services. Both companies will maintain a partnership with Prince Sterilization Service to provide testing needed to certify products.
